FDA Approves Targeted Radiotherapy for Neuroendocrine Tumors
The U.S. Food and Drug Administration (FDA) recently added a new therapeutic to the armamentarium for oncologists treating patients...
Category: AACR
The U.S. Food and Drug Administration (FDA) recently added a new therapeutic to the armamentarium for oncologists treating patients...
In honor of International Day of Women and Girls in Science, a United Nations initiative aimed at narrowing a...
The American Association for Cancer Research (AACR) recently appointed Chi Van Dang, MD, PhD, as the new editor-in-chief of...
The American Association for Cancer Research (AACR) is proud to support World Cancer Day, a yearly initiative of the...
The obesity epidemic shows no signs of abating. The World Health Organization estimates that the proportion of the world’s...
Medical risks of obesity include high blood pressure, type 2 diabetes, and cardiovascular diseases. Additionally, obesity has been associated...
Compared to treatment advances for other types of cancer, progress in treating brain cancer has been frustratingly slow. Still,...
A diverse group of about 220 physicians, patient advocates, and scientists in basic, translational, and clinical lung cancer research...
This past year has been a year of many “firsts” for the oncology community, with several revolutionary advances in...
As 2017 draws to a close, I’ve been reflecting on another year in cancer research. As Chief Executive Officer...